The epigallocatechin gallate derivative Y6 reverses drug resistance mediated by the ABCB1 transporter both in vitro and in vivo

• Asıl Yazarlar: Yan Wen (Yazar), Ruiqiang Zhao (Yazar), Pranav Gupta (Yazar), Yingfang Fan (Yazar), Yunkai Zhang (Yazar), Zhenguang Huang (Yazar), Xiaohui Li (Yazar), Yuangang Su (Yazar), Lijuan Liao (Yazar), Yu-An Xie (Yazar), Donghua Yang (Yazar), Zhe-Sheng Chen (Yazar), Gang Liang (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2019-03-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Previously, we reported that Y6, a new epigallocatechin gallate derivative, is efficacious in reversing doxorubicin (DOX)--mediated resistance in hepatocellular carcinoma BEL-7404/DOX cells. In this study, we evaluated the efficacy of Y6 in reversing drug resistance both in vitro and in vivo by dete...